Holdings
127
Well diversified
Top 10 weight
54%
Concentration
Active share
-
Style
Equity
100%
Asset allocation
Portfolio
-Sectors
6High-conviction bets
-Top sector wt.
0.0%Cash
Market-cap allocation
Large cap43%
Mid cap28%
Small cap28%
Asset allocation
Equity100%
Top holdings
12.9%
5.7%
5.4%
5.4%
Cipla LimitedEQUITY
5.3%5.3%
Lupin LimitedEQUITY
3.8%Laurus Labs LimitedEQUITY
3.7%3.2%
3.0%
Aurobindo Pharma LimitedEQUITY
2.8%2.1%
2.1%
Biocon LimitedEQUITY
1.9%Mankind Pharma LimitedEQUITY
1.8%1.8%
1.5%
1.3%
Gland Pharma LimitedEQUITY
1.3%1.2%
1.2%
1.1%
Wockhardt LimitedEQUITY
1.0%1.0%
Ajanta Pharma LimitedEQUITY
0.9%0.9%
Abbott India LimitedEQUITY
0.8%0.8%
0.8%
Granules India LimitedEQUITY
0.8%Global Health LimitedEQUITY
0.7%0.7%
Piramal Pharma LimitedEQUITY
0.7%0.6%
0.6%
Natco Pharma LimitedEQUITY
0.5%0.5%
0.5%
0.5%
0.5%
0.5%
Shilpa Medicare LimitedEQUITY
0.5%Pfizer LimitedEQUITY
0.4%0.4%
Poly Medicure LimitedEQUITY
0.4%0.4%
Marksans Pharma LimitedEQUITY
0.4%0.4%
Indegene LimitedEQUITY
0.4%AI Smart summary
Pros
- Well-diversified across 127 holdings.
Cons
- No major structural red flags.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in this category.
No peers found in this category.
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
75.6%
23.7%
0.5%